These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718 [TBL] [Abstract][Full Text] [Related]
24. Resolvin D1: A key endogenous inhibitor of neuroinflammation. Roohbakhsh A; Etemad L; Karimi G Biofactors; 2022 Sep; 48(5):1005-1026. PubMed ID: 36176016 [TBL] [Abstract][Full Text] [Related]
25. Ketamine: A tale of two enantiomers. Jelen LA; Young AH; Stone JM J Psychopharmacol; 2021 Feb; 35(2):109-123. PubMed ID: 33155503 [TBL] [Abstract][Full Text] [Related]
26. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine. Deyama S; Kondo M; Shimada S; Kaneda K Transl Psychiatry; 2022 May; 12(1):178. PubMed ID: 35577782 [TBL] [Abstract][Full Text] [Related]
27. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein. Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440 [TBL] [Abstract][Full Text] [Related]
29. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Tian H; Lu Y; Sherwood AM; Hongqian D; Hong S Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3613-20. PubMed ID: 19443724 [TBL] [Abstract][Full Text] [Related]
30. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798 [TBL] [Abstract][Full Text] [Related]
31. Molecular Dynamics Simulations Provide Insight into the Loading Efficiency of Proresolving Lipid Mediators Resolvin D1 and D2 in Cell Membrane-Derived Nanovesicles. Gc JB; Szlenk CT; Gao J; Dong X; Wang Z; Natesan S Mol Pharm; 2020 Jun; 17(6):2155-2164. PubMed ID: 32374613 [TBL] [Abstract][Full Text] [Related]
32. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Klein CP; Sperotto ND; Maciel IS; Leite CE; Souza AH; Campos MM Neuropharmacology; 2014 Nov; 86():57-66. PubMed ID: 24929111 [TBL] [Abstract][Full Text] [Related]
33. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Xu ZZ; Zhang L; Liu T; Park JY; Berta T; Yang R; Serhan CN; Ji RR Nat Med; 2010 May; 16(5):592-7, 1p following 597. PubMed ID: 20383154 [TBL] [Abstract][Full Text] [Related]
34. Changes in plasma lipoxin A4, resolvins and CD59 levels after ischemic and traumatic brain injuries in rats. Jung JS; Kho AR; Lee SH; Choi BY; Kang SH; Koh JY; Suh SW; Song DK Korean J Physiol Pharmacol; 2020 Mar; 24(2):165-171. PubMed ID: 32140040 [TBL] [Abstract][Full Text] [Related]
35. Combined administration of docosahexaenoic acid and thyroid hormone synergistically enhances rat liver levels of resolvins RvD1 and RvD2. Videla LA; Vargas R; Valenzuela R; Muñoz P; Corbari A; Hernandez-Rodas MC Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():42-46. PubMed ID: 30553402 [TBL] [Abstract][Full Text] [Related]
36. Reduction of high-fat diet-induced liver proinflammatory state by eicosapentaenoic acid plus hydroxytyrosol supplementation: involvement of resolvins RvE1/2 and RvD1/2. Echeverría F; Valenzuela R; Espinosa A; Bustamante A; Álvarez D; Gonzalez-Mañan D; Ortiz M; Soto-Alarcon SA; Videla LA J Nutr Biochem; 2019 Jan; 63():35-43. PubMed ID: 30321750 [TBL] [Abstract][Full Text] [Related]
37. Ketamine and its metabolites: Potential as novel treatments for depression. Zhang K; Yao Y; Hashimoto K Neuropharmacology; 2023 Jan; 222():109305. PubMed ID: 36354092 [TBL] [Abstract][Full Text] [Related]
38. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184 [TBL] [Abstract][Full Text] [Related]
39. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Lamon-Fava S; So J; Mischoulon D; Ziegler TR; Dunlop BW; Kinkead B; Schettler PJ; Nierenberg AA; Felger JC; Maddipati KR; Fava M; Rapaport MH Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102219. PubMed ID: 33316626 [TBL] [Abstract][Full Text] [Related]
40. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. Clària J; Dalli J; Yacoubian S; Gao F; Serhan CN J Immunol; 2012 Sep; 189(5):2597-605. PubMed ID: 22844113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]